Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Diagnostics (Basel, Switzerland)|March 28, 2025
Photon-Counting CT Scan Phantom Study: Stability of Radiomics FeaturesLama Dawi, Kodjodenis Amouzouga, Serge Muller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2023
Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on ImmunotherapyYounes Belkouchi, Hugues Talbot, Nathalie Lassau, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2025
The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patientsAntoine Italiano, Othilie Gautier, Jules Dupont, et al.
Cancers|January 10, 2026
The Role of Computed Tomography-Determined Total Tumor Volume at Baseline in Predicting Outcomes of Patients with Locally Advanced Unresectable or Metastatic Pancreatic Ductal AdenocarcinomaElissar Moujaes, Jules Dupont, Littisha Lawrance, et al.
European Journal of Cancer (Oxford, England : 1990)|March 19, 2024
Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patientsRémy Barbe, Younes Belkouchi, Yves Menu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2026
Integrating tumor volumetry and liquid biopsy: a New model to define prognosis in advanced pancreatic ductal adenocarcinomaVictor Robic, Maxime Collin, Jules Dupont, et al.
Diagnostic and Interventional Imaging|July 24, 2024
Detection and characterization of pancreatic lesion with artificial intelligence: The SFR 2023 artificial intelligence data challengeTheodore Aouad, Valerie Laurent, Paul Levant, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2026
Role of ctDNA Tumor Fraction in Selecting Immunotherapy Based Regimens in Advanced Non-small Cell Lung CancerFilippo G Dall'Olio, Wael Zrafi, Damien Vasseur, et al.
Diagnostic and Interventional Imaging|June 8, 2025
Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancerGhina Jardali, Littisha Lawrance, Lama Dawi, et al.
Radiology|November 26, 2024
Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with MetastasesLama Dawi, Younes Belkouchi, Littisha Lawrance, et al.
Pageof 1